about
Synthesis and antiproliferative activity of hydroxyferrocifen hybrids against triple-negative breast cancer cells.Site-specific conjugation of metal carbonyl dendrimer to antibody and its use as detection reagent in immunoassay.Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules.Oxidative metabolism of ferrocene analogues of tamoxifen: characterization and antiproliferative activities of the metabolites.Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative Transformation.Ferrocifen type anti cancer drugs.Ferrocifen derivatives that induce senescence in cancer cells: selected examples.Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules.Quantitative analyses of ROS and RNS production in breast cancer cell lines incubated with ferrocifens.Cytotoxic triosmium carbonyl clusters: a structure-activity relationship study.Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species.The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer.Ferrocenyl catechols: synthesis, oxidation chemistry and anti-proliferative effects on MDA-MB-231 breast cancer cells.Synchrotron radiation FTIR detection of a metal-carbonyl tamoxifen analog. Correlation with luminescence microscopy to study its subcellular distribution.In vitro inhibitory properties of ferrocene-substituted chalcones and aurones on bacterial and human cell cultures.Ferrocenyl chalcone difluoridoborates inhibit HIV-1 integrase and display low activity towards cancer and endothelial cells.Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.Synthetic and mechanistic pathways of cis and trans-hydroxytamoxifen drug derivatives reacting with Cp*Rh complexes that involve η1-N, η2-N,O, η1-O, and η6 bonding modes, via a novel N-π rearrangement; relative binding affinities and computer dockinOrganometallic cyclic polyphenols derived from 1,2-(alpha-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells.Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.Ferrocenyl quinone methides as strong antiproliferative agents: formation by metabolic and chemical oxidation of ferrocenyl phenols.Evaluation of cytotoxic properties of organometallic ferrocifens on melanocytes, primary and metastatic melanoma cell lines.Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment.The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity.Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: synthesis and biological behaviour.Deciphering the activation sequence of ferrociphenol anticancer drug candidates.Patterns of pulmonary tuberculosis on FDG-PET/CT.Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model.Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.Osmocenyl-tamoxifen derivatives target the thioredoxin system leading to a redox imbalance in Jurkat cells.Synthesis of metal-carbonyl-dendrimer-antibody immunoconjugates: towards a new format for carbonyl metallo immunoassay.Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules.Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells.Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.Evidence for Targeting Thioredoxin Reductases with Ferrocenyl Quinone Methides. A Possible Molecular Basis for the Antiproliferative Effect of Hydroxyferrocifens on Cancer CellsSubcellular IR imaging of a metal-carbonyl moiety using photothermally induced resonanceInfluence of the side-chain length on the cellular uptake and the cytotoxicity of rhenium triscarbonyl derivatives: a bimodal infrared and luminescence quantitative study
P50
Q30683354-391C66C0-1299-4D33-BB36-CC72E98CDF94Q33678409-F218E163-1377-466A-96DC-74E87A42D823Q35105127-CBBA056B-5570-49A8-A0B0-CC79A52142F3Q35604815-D584DCED-E3EC-4859-9D5E-07528BFD26DBQ36045117-EE53A11E-7CBB-4A4A-8F5E-FCAEB41F8E1FQ38612680-F12A6159-A4A9-4F79-B218-1B67FD26D87DQ38952792-521EBA35-1DB0-40A4-BB79-E045B465B445Q38993501-14505CCD-FDEC-449C-A604-64EE428B0705Q38997703-2531E79B-62BB-42A9-BBC2-B98E84544505Q39032502-D6E9B933-A568-4FA6-AA14-50148F5263CDQ39096632-148090B0-60CB-4099-8787-E1C0881D9577Q39137899-C76B55C7-EDCF-4A1D-9A1C-CB6A5EB33E75Q39346477-AF9CAC71-757E-4273-8B1B-75D56E583CBDQ39397946-8AFBD394-64CD-468D-9C77-52576015561CQ39413094-CC5053BE-BAB8-4385-A50D-27EF2F62273BQ39480042-02489EFD-CFC2-4D6F-9203-B8F2808963B4Q39545848-3168706D-3F85-4C16-8208-17F6A4E5E7ABQ39625307-D7608275-4D2D-429D-B3C3-46A792893CE9Q39682941-C0690C64-6709-46D0-B136-AEFD3AD0A68BQ39775848-C07304F4-8C83-4D8B-93F3-189C3AA5D1E6Q39781648-F84830AF-B35B-41AF-9556-12446CFF471CQ39941272-5A4DD73B-FB74-42A5-A175-977E3FD179FFQ39967948-962D8F2A-3AED-408B-8D67-F6A5C2627E03Q40104107-1528641B-8A20-430C-AC3B-2C2BFD80A4B0Q40223467-36828EF7-1EE7-4868-B462-FEF526AA4C2BQ40435765-BA86E696-5A39-4C08-A71A-52604283B995Q40490612-5F1410E5-3AB1-4D24-B629-261B7CB5A4F1Q44853406-D1F4331F-4C4A-49F0-B9DA-1BDA706F5AB5Q45854352-FE33722A-096C-40DA-A310-9D433CC6BECEQ45997848-7A30453C-DABE-4093-985A-B23058578204Q46454070-B9ED4322-1669-4D39-B4AB-7131BA71EA48Q46555674-16963EB5-21C6-43CA-A947-6D3796B26ED7Q47375006-1B87A416-98BA-4538-BFB3-B315254FA9B3Q48529455-63336C78-8A0C-4C26-B577-4F1D585DC3DEQ49146067-E86DC46A-A5CE-4AE7-BAF3-200D05C452DFQ53745075-1FF29242-3C08-4F61-99C0-FF91D31C89BFQ55463127-BBC89BD2-5D53-47D4-BB54-FF56ED55C405Q60453029-B52DCF25-A7BD-4710-8B9A-A89ADBDE4CEFQ85185884-F0B4A765-4296-44AA-A81B-7A357DC15826Q88098338-F065B1B7-54F1-4636-BDCA-FA637DD849DF
P50
description
researcher ORCID ID = 0000-0002-4044-2730
@en
wetenschapper
@nl
name
A Vessieres
@ast
A Vessieres
@en
A Vessieres
@nl
type
label
A Vessieres
@ast
A Vessieres
@en
A Vessieres
@nl
prefLabel
A Vessieres
@ast
A Vessieres
@en
A Vessieres
@nl
P106
P31
P496
0000-0002-4044-2730